------------------------------------------------------------------------

Contents (.PDF)           Federal Register

Contents (.TXT)                               Vol. 64, No.38

Friday, February 26, 1999

------------------------------------------------------------------------

Food and DrugAdministration
RULES
NADA 141-063, CVM98161. Implantation or Injectable Dosage Form New Animal Drugs; Florfenicol Solution. Page 9435 [FR Doc. 99-4762] [TXT]  [PDF]
Freedom of Information Summary
NOTICES
Docket No. 93N-0371, OC9945. Agency Information Collection Activities; Announcement of OMB Approval; Prescription Drug Product Labeling, Medication Guide Requirements.  Page 9515 [FR Doc. 99-4765] [TXT]  [PDF]
Supporting Statement
Docket No. 97N-0165, OC9938. Agency Information Collection Activities; Announcement of OMB Approval; Regulations Requiring Manufacturers to Assess the Safety and Effectiveness of New Drugs and Biological Products in Pediatric Patients.  Page 9515 [FR Doc. 99-4766] [TXT]  [PDF]
Supporting Statement
DOCKET No. 84N-0102, OC998. Cumulative List of Orphan Drug and Biological Designations.  Pages 9515-9516 [FR Doc. 99-4764]  [TXT]  [PDF]

Docket No. 95D-0349, CDER992. Guidance for Industry on SUPAC09IR/MR: Immediate Release and Modified Release Solid Oral Dosage Forms, Manufacturing Equipment Addendum; Availability. Page 9516 [FR Doc. 99-4767] [TXT]  [PDF]

Guidance
Docket No. 99D-0236, CDER98198. Draft Guidance for Industry on Skin Irritation and Sensitization Testing of Generic Transdermal Drug Products; Availability.  Page 9516-9517 [FR Doc. 99-4763] [TXT]  [PDF]  Written comments by April 27, 1999
Draft Guidance